Please login to the form below

Not currently logged in
Email:
Password:

INC Research appoints Dr Martin Sullivan

He joins the CRO as executive medical director for cardiovascular medicine

INC Research has appointed Dr Martin Sullivan as its new executive director for cardiovascular medicine.  

He has spent more than 25 years in medical practice and clinical research and prior to joining the US-based clinical research organisation (CRO) Dr Sullivan was a research consultant specialising in non-invasive cardiology.  

His career has included stints as the director of the Duke Center for Integrative Medicine; director of cardiovascular research at the Heartland Regional Medical Center in St. Joseph's, Missouri; and a senior research consultant in the division of cardiology at the University of North Carolina.  

Sally Osmond, general manager of cardiovascular and endocrinology clinical development at INC Research, said: "The prevalence of cardiovascular diseases provides significant opportunity for the development of new therapies to improve the health and overall wellbeing of many patients worldwide.  

"Marty is a highly respected cardiologist with extensive experience both in practice and in clinical development, having implemented more than 100 clinical research projects. We're thrilled to have a thought leader of his calibre to lead development of these complex trials."  

16th October 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics